Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 936 entries
Sorted by: Best Match Show Resources per page
Therapy of NMO spectrum disorders.

Annals of Indian Academy of Neurology

Biswas A, Mukherjee A.
PMID: 26538843
Ann Indian Acad Neurol. 2015 Sep;18:S16-23. doi: 10.4103/0972-2327.164818.

Neuromyelitis optica (NMO) is an autoimmune demyelinating condition of the central nervous system often associated with aquaporin-4 (AQP4) autoantibodies manifesting as severe optic neuritis and long segment myelitis with tendency to relapse. Seronegative patients and who do not meet...

Cite
Biswas A, Mukherjee A. Therapy of NMO spectrum disorders. Ann Indian Acad Neurol. 2015;18:S16-23doi: 10.4103/0972-2327.164818.
Biswas, A., & Mukherjee, A. (2015). Therapy of NMO spectrum disorders. Annals of Indian Academy of Neurology, 18S16-23. https://doi.org/10.4103/0972-2327.164818
Biswas, Atanu, and Mukherjee, Arabinda. "Therapy of NMO spectrum disorders." Annals of Indian Academy of Neurology vol. 18 (2015): S16-23. doi: https://doi.org/10.4103/0972-2327.164818
Biswas A, Mukherjee A. Therapy of NMO spectrum disorders. Ann Indian Acad Neurol. 2015 Sep;18:S16-23. doi: 10.4103/0972-2327.164818. PMID: 26538843; PMCID: PMC4604692.
Copy Download .nbib Format: NLM
Review on immunosuppression in liver transplantation.

World journal of hepatology

Moini M, Schilsky ML, Tichy EM.
PMID: 26052381
World J Hepatol. 2015 Jun 08;7(10):1355-68. doi: 10.4254/wjh.v7.i10.1355.

The optimal level of immunosuppression in solid organ transplantation, in particular for the liver, is a delicate balance between the benefit of preventing rejection and the adverse side effects of immunosuppression. There is uncertainty about when this level is...

Cite
Moini M, Schilsky ML, Tichy EM. Review on immunosuppression in liver transplantation. World J Hepatol. 2015;7(10):1355-68doi: 10.4254/wjh.v7.i10.1355.
Moini, M., Schilsky, M. L., & Tichy, E. M. (2015). Review on immunosuppression in liver transplantation. World journal of hepatology, 7(10), 1355-68. https://doi.org/10.4254/wjh.v7.i10.1355
Moini, Maryam, et al. "Review on immunosuppression in liver transplantation." World journal of hepatology vol. 7,10 (2015): 1355-68. doi: https://doi.org/10.4254/wjh.v7.i10.1355
Moini M, Schilsky ML, Tichy EM. Review on immunosuppression in liver transplantation. World J Hepatol. 2015 Jun 08;7(10):1355-68. doi: 10.4254/wjh.v7.i10.1355. PMID: 26052381; PMCID: PMC4450199.
Copy Download .nbib Format: NLM
T cell unresponsiveness in a pediatric cystic fibrosis patient: a case report.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Kushwah R, Gagnon S, Sweezey NB.
PMID: 24438707
Allergy Asthma Clin Immunol. 2014 Jan 17;10(1):2. doi: 10.1186/1710-1492-10-2.

A girl was diagnosed with cystic fibrosis (CF) at birth, with repeatedly positive sweat tests and homozygous F508del mutations of her CF transmembrane conductance regulator (CFTR) gene. From an early age, her lung disease was more severe than her...

Cite
Kushwah R, Gagnon S, Sweezey NB. T cell unresponsiveness in a pediatric cystic fibrosis patient: a case report. Allergy Asthma Clin Immunol. 2014;10(1):2doi: 10.1186/1710-1492-10-2.
Kushwah, R., Gagnon, S., & Sweezey, N. B. (2014). T cell unresponsiveness in a pediatric cystic fibrosis patient: a case report. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 10(1), 2. https://doi.org/10.1186/1710-1492-10-2
Kushwah, Rahul, et al. "T cell unresponsiveness in a pediatric cystic fibrosis patient: a case report." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 10,1 (2014): 2. doi: https://doi.org/10.1186/1710-1492-10-2
Kushwah R, Gagnon S, Sweezey NB. T cell unresponsiveness in a pediatric cystic fibrosis patient: a case report. Allergy Asthma Clin Immunol. 2014 Jan 17;10(1):2. doi: 10.1186/1710-1492-10-2. PMID: 24438707; PMCID: PMC3896844.
Copy Download .nbib Format: NLM
Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases.

Case reports in neurology

Cherin P, Delain JC, de Jaeger C, Crave JC.
PMID: 26600787
Case Rep Neurol. 2015 Nov 05;7(3):227-32. doi: 10.1159/000441490. eCollection 2015.

INTRODUCTION: Inclusion body myositis (IBM) is a slowly progressive degenerative inflammatory disorder affecting both proximal and distal muscles. Immunosuppressive therapies are generally ineffective in the treatment of this disorder, and most patients are resistant to steroid therapy. Some benefits...

Cite
Cherin P, Delain JC, de Jaeger C, et al. Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases. Case Rep Neurol. 2015;7(3):227-32doi: 10.1159/000441490.
Cherin, P., Delain, J. C., de Jaeger, C., & Crave, J. C. (2015). Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases. Case reports in neurology, 7(3), 227-32. https://doi.org/10.1159/000441490
Cherin, Patrick, et al. "Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases." Case reports in neurology vol. 7,3 (2015): 227-32. doi: https://doi.org/10.1159/000441490
Cherin P, Delain JC, de Jaeger C, Crave JC. Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases. Case Rep Neurol. 2015 Nov 05;7(3):227-32. doi: 10.1159/000441490. eCollection 2015. PMID: 26600787; PMCID: PMC4649754.
Copy Download .nbib Format: NLM
Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders.

World journal of gastrointestinal pathophysiology

Lam GY, Halloran BP, Peters AC, Fedorak RN.
PMID: 26600976
World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):181-92. doi: 10.4291/wjgp.v6.i4.181.

Immunosuppressive agents, such as thiopurines, methotrexate, and biologics, have revolutionized the treatment of inflammatory bowel disease (IBD). However, a number of case reports, case control studies and retrospective studies over the last decade have identified a concerning link between...

Cite
Lam GY, Halloran BP, Peters AC, et al. Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders. World J Gastrointest Pathophysiol. 2015;6(4):181-92doi: 10.4291/wjgp.v6.i4.181.
Lam, G. Y., Halloran, B. P., Peters, A. C., & Fedorak, R. N. (2015). Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders. World journal of gastrointestinal pathophysiology, 6(4), 181-92. https://doi.org/10.4291/wjgp.v6.i4.181
Lam, Grace Y, et al. "Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders." World journal of gastrointestinal pathophysiology vol. 6,4 (2015): 181-92. doi: https://doi.org/10.4291/wjgp.v6.i4.181
Lam GY, Halloran BP, Peters AC, Fedorak RN. Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders. World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):181-92. doi: 10.4291/wjgp.v6.i4.181. PMID: 26600976; PMCID: PMC4644882.
Copy Download .nbib Format: NLM
Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.

Dermatology and therapy

Weidmann A, Foulkes AC, Kirkham N, Reynolds NJ.
PMID: 24942326
Dermatol Ther (Heidelb). 2014 Dec;4(2):145-56. doi: 10.1007/s13555-014-0056-z. Epub 2014 Jun 19.

Methotrexate continues to be one of the most widely used systemic immunosuppressive agents in dermatology. In addition to the important, well-characterized adverse effects such as hepatotoxicity and myelosuppression, methotrexate may induce a number of rare cutaneous adverse events including...

Cite
Weidmann A, Foulkes AC, Kirkham N, et al. Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature. Dermatol Ther (Heidelb). 2014;4(2):145-56doi: 10.1007/s13555-014-0056-z.
Weidmann, A., Foulkes, A. C., Kirkham, N., & Reynolds, N. J. (2014). Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature. Dermatology and therapy, 4(2), 145-56. https://doi.org/10.1007/s13555-014-0056-z
Weidmann, Anja, et al. "Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature." Dermatology and therapy vol. 4,2 (2014): 145-56. doi: https://doi.org/10.1007/s13555-014-0056-z
Weidmann A, Foulkes AC, Kirkham N, Reynolds NJ. Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature. Dermatol Ther (Heidelb). 2014 Dec;4(2):145-56. doi: 10.1007/s13555-014-0056-z. Epub 2014 Jun 19. PMID: 24942326; PMCID: PMC4257944.
Copy Download .nbib Format: NLM
Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients.

Biotechnology, biotechnological equipment

Filipov JJ, Zlatkov BK, Dimitrov EP, Svinarov D.
PMID: 26019648
Biotechnol Biotechnol Equip. 2015 Mar 04;29(2):331-335. doi: 10.1080/13102818.2014.995415. Epub 2015 Jan 08.

There is a growing body of evidence for the protective role of vitamin D in diabetes mellitus (DM), infection, cancer, cardiovascular disease, immune disorders and kidney function. Considering the reported high prevalence of vitamin D insufficiency among kidney transplant...

Cite
Filipov JJ, Zlatkov BK, Dimitrov EP, et al. Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients. Biotechnol Biotechnol Equip. 2015;29(2):331-335doi: 10.1080/13102818.2014.995415.
Filipov, J. J., Zlatkov, B. K., Dimitrov, E. P., & Svinarov, D. (2015). Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients. Biotechnology, biotechnological equipment, 29(2), 331-335. https://doi.org/10.1080/13102818.2014.995415
Filipov, Jean Jeanov, et al. "Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients." Biotechnology, biotechnological equipment vol. 29,2 (2015): 331-335. doi: https://doi.org/10.1080/13102818.2014.995415
Filipov JJ, Zlatkov BK, Dimitrov EP, Svinarov D. Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients. Biotechnol Biotechnol Equip. 2015 Mar 04;29(2):331-335. doi: 10.1080/13102818.2014.995415. Epub 2015 Jan 08. PMID: 26019648; PMCID: PMC4433925.
Copy Download .nbib Format: NLM
Immunosuppressive agents are associated with peptic ulcer bleeding.

Experimental and therapeutic medicine

Tomizawa M, Shinozaki F, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.
PMID: 28565788
Exp Ther Med. 2017 May;13(5):1927-1931. doi: 10.3892/etm.2017.4214. Epub 2017 Mar 09.

Peptic ulcer bleeding can be fatal. Non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids and immunosuppressive agents are administered for long-term usage. The present study assessed the association between peptic ulcer bleeding and administration of NSAIDs, corticosteroids and immunosuppressive agents. Furthermore, the...

Cite
Tomizawa M, Shinozaki F, Hasegawa R, et al. Immunosuppressive agents are associated with peptic ulcer bleeding. Exp Ther Med. 2017;13(5):1927-1931doi: 10.3892/etm.2017.4214.
Tomizawa, M., Shinozaki, F., Hasegawa, R., Shirai, Y., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., & Ishige, N. (2017). Immunosuppressive agents are associated with peptic ulcer bleeding. Experimental and therapeutic medicine, 13(5), 1927-1931. https://doi.org/10.3892/etm.2017.4214
Tomizawa, Minoru, et al. "Immunosuppressive agents are associated with peptic ulcer bleeding." Experimental and therapeutic medicine vol. 13,5 (2017): 1927-1931. doi: https://doi.org/10.3892/etm.2017.4214
Tomizawa M, Shinozaki F, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N. Immunosuppressive agents are associated with peptic ulcer bleeding. Exp Ther Med. 2017 May;13(5):1927-1931. doi: 10.3892/etm.2017.4214. Epub 2017 Mar 09. PMID: 28565788; PMCID: PMC5443275.
Copy Download .nbib Format: NLM
Clinical Characteristics and Outcome of Primary Sjogren's Syndrome: A Large Asian Indian Cohort.

The open rheumatology journal

Sandhya P, Jeyaseelan L, Scofield RH, Danda D.
PMID: 26161156
Open Rheumatol J. 2015 Jun 26;9:36-45. doi: 10.2174/1874312901409010036. eCollection 2015.

OBJECTIVE: To characterise the clinical features, immunological profile and outcome in a cohort of Asian Indian patients with primary Sjögren's syndrome (SS).METHODS: Electronic medical records from a tertiary care teaching hospital in south India were screened for SS between...

Cite
Sandhya P, Jeyaseelan L, Scofield RH, et al. Clinical Characteristics and Outcome of Primary Sjogren's Syndrome: A Large Asian Indian Cohort. Open Rheumatol J. 2015;9:36-45doi: 10.2174/1874312901409010036.
Sandhya, P., Jeyaseelan, L., Scofield, R. H., & Danda, D. (2015). Clinical Characteristics and Outcome of Primary Sjogren's Syndrome: A Large Asian Indian Cohort. The open rheumatology journal, 936-45. https://doi.org/10.2174/1874312901409010036
Sandhya, Pulukool, et al. "Clinical Characteristics and Outcome of Primary Sjogren's Syndrome: A Large Asian Indian Cohort." The open rheumatology journal vol. 9 (2015): 36-45. doi: https://doi.org/10.2174/1874312901409010036
Sandhya P, Jeyaseelan L, Scofield RH, Danda D. Clinical Characteristics and Outcome of Primary Sjogren's Syndrome: A Large Asian Indian Cohort. Open Rheumatol J. 2015 Jun 26;9:36-45. doi: 10.2174/1874312901409010036. eCollection 2015. PMID: 26161156; PMCID: PMC4493630.
Copy Download .nbib Format: NLM
Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis.

Experimental and therapeutic medicine

Liu Y, Xiao J, Shi X, Hao G, Chen Q, Zhou J, Wei X.
PMID: 26889216
Exp Ther Med. 2016 Jan;11(1):49-56. doi: 10.3892/etm.2015.2860. Epub 2015 Nov 12.

Immunoglobulin A nephropathy (IgAN) is one of the most common types of primary glomerular disease. Immunosuppressive treatment for patients with IgAN remains controversial. The present meta-analysis aimed to assess the efficacy and safety of various immunosuppressive agents compared with...

Cite
Liu Y, Xiao J, Shi X, et al. Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis. Exp Ther Med. 2015;11(1):49-56doi: 10.3892/etm.2015.2860.
Liu, Y., Xiao, J., Shi, X., Hao, G., Chen, Q., Zhou, J., & Wei, X. (2016). Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis. Experimental and therapeutic medicine, 11(1), 49-56. https://doi.org/10.3892/etm.2015.2860
Liu, Yanli, et al. "Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis." Experimental and therapeutic medicine vol. 11,1 (2016): 49-56. doi: https://doi.org/10.3892/etm.2015.2860
Liu Y, Xiao J, Shi X, Hao G, Chen Q, Zhou J, Wei X. Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis. Exp Ther Med. 2016 Jan;11(1):49-56. doi: 10.3892/etm.2015.2860. Epub 2015 Nov 12. PMID: 26889216; PMCID: PMC4726883.
Copy Download .nbib Format: NLM
De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience.

Kidney research and clinical practice

Cho YH, Kang SH, Kim Y, Lee MH, An GH, Chung BH, Choi BS, Yang CW, Kim YS, Choi YJ, Park CW.
PMID: 26877927
Kidney Res Clin Pract. 2013 Sep;32(3):121-6. doi: 10.1016/j.krcp.2013.07.004. Epub 2013 Aug 30.

BACKGROUND: Nephrotic syndrome (NS) and proteinuria are uncommon, often unrecognized manifestations of graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT). Only a few isolated case reports and case series involving smaller number of patients who developed NS after...

Cite
Cho YH, Kang SH, Kim Y, et al. De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience. Kidney Res Clin Pract. 2013;32(3):121-6doi: 10.1016/j.krcp.2013.07.004.
Cho, Y. H., Kang, S. H., Kim, Y., Lee, M. H., An, G. H., Chung, B. H., Choi, B. S., Yang, C. W., Kim, Y. S., Choi, Y. J., & Park, C. W. (2013). De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience. Kidney research and clinical practice, 32(3), 121-6. https://doi.org/10.1016/j.krcp.2013.07.004
Cho, Yul Hee, et al. "De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience." Kidney research and clinical practice vol. 32,3 (2013): 121-6. doi: https://doi.org/10.1016/j.krcp.2013.07.004
Cho YH, Kang SH, Kim Y, Lee MH, An GH, Chung BH, Choi BS, Yang CW, Kim YS, Choi YJ, Park CW. De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience. Kidney Res Clin Pract. 2013 Sep;32(3):121-6. doi: 10.1016/j.krcp.2013.07.004. Epub 2013 Aug 30. PMID: 26877927; PMCID: PMC4714094.
Copy Download .nbib Format: NLM
Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis.

Revista brasileira de hematologia e hemoterapia

Tanizawa RS, Zerbini MC, Rosenfeld R, Kumeda CA, Azevedo RS, Siqueira SA, Velloso ED.
PMID: 28270344
Rev Bras Hematol Hemoter. 2017 Jan - Mar;39(1):4-12. doi: 10.1016/j.bjhh.2016.09.015. Epub 2016 Dec 22.

BACKGROUND: Secondary myeloid neoplasms comprise a group of diseases arising after chemotherapy, radiation, immunosuppressive therapy or from aplastic anemia. Few studies have addressed prognostic factors in these neoplasms.METHOD: Forty-two patients diagnosed from 1987 to 2008 with secondary myeloid neoplasms...

Cite
Tanizawa RS, Zerbini MC, Rosenfeld R, et al. Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis. Rev Bras Hematol Hemoter. 2016;39(1):4-12doi: 10.1016/j.bjhh.2016.09.015.
Tanizawa, R. S., Zerbini, M. C., Rosenfeld, R., Kumeda, C. A., Azevedo, R. S., Siqueira, S. A., & Velloso, E. D. (2017). Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis. Revista brasileira de hematologia e hemoterapia, 39(1), 4-12. https://doi.org/10.1016/j.bjhh.2016.09.015
Tanizawa, Roberta Sandra da Silva, et al. "Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis." Revista brasileira de hematologia e hemoterapia vol. 39,1 (2017): 4-12. doi: https://doi.org/10.1016/j.bjhh.2016.09.015
Tanizawa RS, Zerbini MC, Rosenfeld R, Kumeda CA, Azevedo RS, Siqueira SA, Velloso ED. Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis. Rev Bras Hematol Hemoter. 2017 Jan - Mar;39(1):4-12. doi: 10.1016/j.bjhh.2016.09.015. Epub 2016 Dec 22. PMID: 28270344; PMCID: PMC5339394.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 936 entries